Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 May 10;11(5):e043585.
doi: 10.1136/bmjopen-2020-043585.

Effectiveness and safety of glibenclamide for stroke: protocol for a systematic review and meta-analysis

Lihong Wen #  1 , Bin Huang #  2 , Rong Tu  1 , Kunzhen Wan  1 , Hong Zhang  3 , Xiaoyun Zhang  3
Affiliations

Effectiveness and safety of glibenclamide for stroke: protocol for a systematic review and meta-analysis

Lihong Wen et al. BMJ Open. .

Abstract

Introduction: Despite the continuous improvement in modern medical treatment, stroke is still a leading cause of death and disability worldwide. How to effectively improve the survival rate and reduce disability in patients who had a stroke has become the focus of many investigations. Recent findings concerning the benefits of glibenclamide as a neuroprotective drug have initiated a new area for prospective studies on the effects of sulfonylureas. Given the high mortality and disability associated with stroke, it is essential to weigh the benefits of neuroprotective drugs against their safety. Therefore, the objective of the current study is to conduct a systematic review using meta-analysis to assess the benefits and safety of glibenclamide as a neuroprotective drug.

Methods and analysis: This study will analyse randomised clinical trials (RCTs) and observational studies published up to 31 December 2020 and include direct or indirect evidence. Studies will be retrieved by searching PubMed, EMBASE, Web of Science, the Cochrane Library and China National Knowledge Infrastructure (CNKI) and WanFang Databases. The outcomes of this study will be mortality, scores from the Modified Rankin Scale and the occurrence of hypoglycaemic events. The risk of bias will be assessed using the Cochrane risk of bias assessment instrument for RCTs. A random-effect/fixed-effect model will be used to summarise the estimates of the mean difference/risk ratio using a 95% CI.

Ethics and dissemination: This meta-analysis is a secondary research project, which is based on previously published data. Therefore, ethical approval and informed consent were not required for this meta-analysis. The results of this study will be submitted to a peer-reviewed journal for publication.

Prospero registration number: CRD42020144674.

Keywords: neurological injury; neurotology; stroke.

PubMed Disclaimer

Conflict of interest statement

Competing interests: None declared.

Figures

Figure 1
Figure 1
Flow diagram of study selection process.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

References

    1. Caffes N, Kurland DB, Gerzanich V, et al. . Glibenclamide for the treatment of ischemic and hemorrhagic stroke. Int J Mol Sci 2015;16:4973–84. 10.3390/ijms16034973 - DOI - PMC - PubMed
    1. Feigin VL, Lawes CMM, Bennett DA, et al. . Worldwide stroke incidence and early case fatality reported in 56 population-based studies: a systematic review. Lancet Neurol 2009;8:355–69. 10.1016/S1474-4422(09)70025-0 - DOI - PubMed
    1. Wu S, Wu B, Liu M, et al. . Stroke in China: advances and challenges in epidemiology, prevention, and management. Lancet Neurol 2019;18:394–405. 10.1016/S1474-4422(18)30500-3 - DOI - PubMed
    1. Wang W, Jiang B, Sun H, et al. . Prevalence, incidence, andmortality of stroke in China: results from a nationwide population⁃based survey of 480 687 adults[J]. Circulation 2017;135:759–71. 10.1161/CIRCULATIONAHA.116.025250 - DOI - PubMed
    1. Kurland DB, Tosun C, Pampori A, et al. . Glibenclamide for the treatment of acute CNS injury. Pharmaceuticals 2013;6:1287–303. 10.3390/ph6101287 - DOI - PMC - PubMed

Publication types

LinkOut - more resources